New antibody cocktail reduce symptomatic Covid infection by 81%, Regeneron says

New Phase 3 trial data finds a single shot of Regeneron's Covid-19 antibody cocktail was able to prevent symptomatic Covid-19 among people exposed to the virus, the company said Monday.

Click Here to read the entire article...